M254

· Momenta Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for M254, covering 2024-07-01 to 2024-07-01. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Tolerability of M254 in Healthy Volunteers and Immune Thrombocytopenic Purpura (ITP) Patients [Phase 1, Phase 2]

See pricing